ロード中...
Development of a stable single-vial liposomal formulation for vincristine
Background: Vincristine is a potent therapeutic agent with well-defined activity against hematologic malignancies and solid tumors. It is a cell-cycle specific drug with concentration and exposure duration dependent activity. When used by liposomal delivery, it exhibits enhanced anti-tumor activity....
保存先:
| 出版年: | Int J Nanomedicine |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6596348/ https://ncbi.nlm.nih.gov/pubmed/31296986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S205276 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|